Providencia, Roseller A.
HRN: 28-01-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2025
CEFTRIAXONE 1G (VIAL)
11/04/2025
11/11/2025
IV
2G
OD
FEMORAL NECK FRACTURE
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes